Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Drugs
|
January 4, 2019
Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer
Maxime Chénard-Poirier, Elizabeth C Smyth
Frontiers in Medicine
|
April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
Raghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
Biomarkers in Medicine
|
December 13, 2016
Emerging biomarkers for PD-1 pathway cancer therapy
Joline Sj Lim, Raghav Sundar, Maxime Chénard-Poirier, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
April 16, 2025
Print-It-Yourself Bone Marrow Biopsy Simulator Compared With Human Cadavers
Jean-Francois Leclerc, Tristan Samson-Roy, Maxime Chénard-Poirier, et al.
Oncoimmunology
|
February 16, 2017
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation
Bertrand Routy, Caroline Letendre, David Enot, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials
Alvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Malaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo, et al.
Leukemia & Lymphoma
|
August 12, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Andrée-Anne Pelland, Xavier Deschênes-Simard, Xavier Savard, et al.
Cancer Research Communications
|
August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid Tumors
Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Drugs
|
January 4, 2019
Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer
Maxime Chénard-Poirier, Elizabeth C Smyth
Frontiers in Medicine
|
April 27, 2017
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
Raghav Sundar, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, et al.
Biomarkers in Medicine
|
December 13, 2016
Emerging biomarkers for PD-1 pathway cancer therapy
Joline Sj Lim, Raghav Sundar, Maxime Chénard-Poirier, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
April 16, 2025
Print-It-Yourself Bone Marrow Biopsy Simulator Compared With Human Cadavers
Jean-Francois Leclerc, Tristan Samson-Roy, Maxime Chénard-Poirier, et al.
Oncoimmunology
|
February 16, 2017
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation
Bertrand Routy, Caroline Letendre, David Enot, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials
Alvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Malaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo, et al.
Leukemia & Lymphoma
|
August 12, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Andrée-Anne Pelland, Xavier Deschênes-Simard, Xavier Savard, et al.
Cancer Research Communications
|
August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid Tumors
Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Page
of 2